HPV16 E2 gene disruption and polymorphisms of E2 and LCR: Some significant associations with cervical cancer in Indian women

被引:37
作者
Bhattacharjee, B [1 ]
Sengupta, S [1 ]
机构
[1] Indian Stat Inst, Human Genet Unit, Kolkata 700108, W Bengal, India
关键词
cervical cancer; human papillomavirus type 16; E2; disruption; LCR variation; Indian women;
D O I
10.1016/j.ygyno.2005.09.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. We evaluated the status of the HPV16 E2 gene (disrupted or intact), nucleotide sequence alterations within intact E2 genes and LCR of HPV16 isolates in a group of CaCx cases (invasive squamous cell carcinomas, n = 8 1) and population controls (normal cervical scrapes, n = 27) from Indian women. Methods. E2 disruption was detected by amplifying the entire E2 gene with single set of primers, while overlapping primers were used to determine if any particular region got selectively disrupted. Nucleotide variations in E2 and LCR were analyzed by PCR amplification followed by bi-directional sequencing. The associations between the viral factors and CaCx were analyzed using Fisher's Exact or Chi-squared test and interpreted as OR (95% Cl) and P values. Results. E2 disruption was significantly higher among the cases [3.38 (1.07-10.72); P = 0.02], which was maximum in the region between nucleoticles 3650 and 3872 (DNA-binding region). The European (E) variant was found to be the prevalent subgroup (87.76% among cases and 96.30% among the controls), and the remaining samples were Asian-American variants. Among the E subgroup, variation at position 7450 (T > C) within the E2-binding site-IV was found to be significantly higher among the E2 undisrupted cases (21/37; 56.76%), compared to controls (5/18; 27.78%) [3.41 (1.01-11.55); P = 0.03]. Conclusions. Besides HPV16 E2 disruption, LCR 7450T > C variation within undisrupted E2 of E subgroup appears to be a major factor contributing to the risk of CaCx development in Indian women. Furthermore, polymorphisms in the E2 gene of HPV16 may not be significant for disease risk. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 50 条
[1]   Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia [J].
Bontkes, HJ ;
de Gruijl, TD ;
Bijl, A ;
Verheijen, RHM ;
Meijer, CJLM ;
Scheper, RJ ;
Stern, PL ;
Burns, JE ;
Maitland, NJ ;
Walboomers, JMM .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2453-2459
[2]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[3]  
Burk RD, 2003, CANCER RES, V63, P7215
[4]  
Casas L, 1999, INT J CANCER, V83, P449, DOI 10.1002/(SICI)1097-0215(19991112)83:4&lt
[5]  
449::AID-IJC3&gt
[6]  
3.0.CO
[7]  
2-0
[8]   TRANSCRIPTION OF THE TRANSFORMING GENES OF THE ONCOGENIC HUMAN PAPILLOMAVIRUS-16 IS STIMULATED BY TUMOR PROMOTORS THROUGH AP1 BINDING-SITES [J].
CHAN, WK ;
CHONG, T ;
BERNARD, HU ;
KLOCK, G .
NUCLEIC ACIDS RESEARCH, 1990, 18 (04) :763-769
[9]   TRANSCRIPTIONAL REGULATION OF THE HUMAN PAPILLOMAVIRUS-16 E6-E7 PROMOTER BY A KERATINOCYTE-DEPENDENT ENHANCER, AND BY VIRAL E2 TRANSACTIVATOR AND REPRESSOR GENE-PRODUCTS - IMPLICATIONS FOR CERVICAL CARCINOGENESIS [J].
CRIPE, TP ;
HAUGEN, TH ;
TURK, JP ;
TABATABAI, F ;
SCHMID, PG ;
DURST, M ;
GISSMANN, L ;
ROMAN, A ;
TUREK, LP .
EMBO JOURNAL, 1987, 6 (12) :3745-3753
[10]   ANALYSIS OF THE PHYSICAL STATE OF DIFFERENT HUMAN PAPILLOMAVIRUS DNAS IN INTRAEPITHELIAL AND INVASIVE CERVICAL NEOPLASM [J].
CULLEN, AP ;
REID, R ;
CAMPION, M ;
LORINCZ, AT .
JOURNAL OF VIROLOGY, 1991, 65 (02) :606-612